Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations

Analysts at Stifel Nicolaus initiated coverage on CoLucid Pharmaceuticals Inc (NASDAQ: CLCD) with a Buy rating. The target price for CoLucid Pharmaceuticals is set to $15. CoLucid Pharmaceuticals' shares closed at $8.68 on Friday.

Analysts at JP Morgan initiated coverage on aTyr Pharma Inc (NASDAQ: LIFE) with a Overweight rating. aTyr Pharma shares closed at $22.89 on Friday.

Analysts at Cowen & Company initiated coverage on Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP) with a Outperform rating. Adaptimmune Therapeutics' shares closed at $15.43 on Friday.

Leerink Swann initiated coverage on Fate Therapeutics Inc (NASDAQ: FATE) with a Outperform rating. The target price for Fate Therapeutics is set to $10. Fate Therapeutics' shares closed at $6.26 on Friday.

Analysts at Jefferies initiated coverage on Collegium Pharmaceutical Inc (NASDAQ: COLL) with a Buy rating. The target price for Collegium Pharmaceutical is set to $20. Collegium Pharmaceutical's shares closed at $17.00 on Friday.

Goldman Sachs initiated coverage on Tallgrass Energy GP LP (NYSE: TEGP) with a Neutral rating. The target price for Tallgrass Energy is set to $35. Tallgrass Energy shares closed at $32.06 on Friday.

Analysts at UBS initiated coverage on Prothena Corporation PLC (NASDAQ: PRTA) with a Buy rating. The target price for Prothena Corporation is set to $58. Prothena Corporation shares closed at $39.44 on Friday.

Bernstein initiated coverage on PetroChina Company Limited (ADR) (NYSE: PTR) with a Underperform rating. PetroChina shares closed at $118.49 on Friday.

Analysts at Oppenheimer initiated coverage on Affimed NV (NASDAQ: AFMD) with a Outperform rating. The target price for Affimed is set to $14. Affimed shares closed at $10.43 on Friday.

Morgan Stanley initiated coverage on Vanguard Natural Resources, LLC (NASDAQ: VNR) with a Overweight rating. The target price for Vanguard Natural is set to $20. Vanguard Natural shares closed at $15.88 on Friday.

Latest Ratings for CLCD

DateFirmActionFromTo
Jan 2017DowngradesOverweightEqual-Weight
Dec 2016Initiates Coverage OnBuy
Dec 2016Initiates Coverage OnOverweight

View More Analyst Ratings for CLCD
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (AFMD + ADAP)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
VIACJP MorganReinstates50.0
NUVASVB LeerinkMaintains92.0
SRPTCantor FitzgeraldMaintains211.0
SRPTPiperJaffrayMaintains210.0
LULUGoldman SachsMaintains219.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Morning Market Losers

SunTrust Ups Rice Energy Target To $32, Sees 'Continued Growth'